Of note is that the observed median time to onset of the psychiatric AEs in our analysis of the FAERS data aligned with common gastrointestinal AEs such as nausea and vomiting, which were the most frequently reported within the first 30 days of GLP-1 RA treatment ( In this extensive pharmacovigilance study, we observed a significant association between GLP-1 RAs and eight distinct categories of psychiatric AEs, namely, nervousness, stress, eating disorder, fear of injection, sleep disorder due to general medical conditioninsomnia type, binge eating, fear of eating, and self-induced vomiting
Researchers believe that GI-related events and muscle mass loss can be prevented or addressed with appropriate lifestyle modifications (dietary and physical)
You assume full responsibility for safe handling and use in accordance with all applicable regulations.
A trained professional knows the correct technique, including using the right needle to ensure the injection is as comfortable and effective as possible
Dive Insight: Lilly is trying to tackle a fundamental issue with the GLP-1 medicines that have transformed obesity treatment
For semaglutide users actively losing weight, aim for 1.2 to 1.6 grams of protein per kilogram of body weight daily